Etamsilat , Etamsilat – Darnitsa , Etamsilat – KV, Revolad , Nettle grass.

pharmachologic effect

A drug for the prevention and control of bleeding.

Indications for use

Prevention and treatment of bleeding during and after surgery in otolaryngology, gynecology, obstetrics, urology, dentistry, ophthalmology, plastic surgery; prevention and treatment of capillary bleeding of various etiology and localization: hematuria, metrorrhagia, primary menorrhagia in women with intrauterine contraceptives, nosebleeds, bleeding with gingivitis.

Method of administration and dosage

Pills . The daily dose is: 1-2 tablets 3-4 times a day. In severe cases, the dose is 3 tablets 3-4 times a day. When menorrhagia appoint 3-4 tablets a day, from 5 days before the expected onset of menstruation and up to 5 – th day of the next menstrual cycle. After surgery, use 1-2 tablets every 6 hours until the risk of bleeding disappears. 

– p for injection.   Apply intravenously (slowly) or intramuscularly. The optimal dose of etamsylate for adults   is 10–20 mg / kg and is administered in 3-4 divided doses. In most cases, the daily dose is 1-2 ampoules 3-4 times a day. Before surgery, 1–2 ampoules are injected intravenously or intramuscularly. During the operation, 1–2 ampoules are administered intravenously; administration at the same dose can be repeated. After surgery, 1–2 ampoules are injected every 6 hours until the risk of bleeding disappears. In Neonatal Dicynonum injected i / m or / in a dose of 12.5 mg / kg (0.1 ml = 12.5 mg). Treatment should be started within the first 2 hours after birth and the drug should be used every 6 hours for 4 days up to a total dose of 200 mg / kg.         

Dicinone can be applied topically (skin graft, tooth extraction) using a sterile gauze pad moistened with the drug.

Side effects

Rarely – nausea, epigastric pain , dizziness, skin rash. In applying p – pa Injection: headache, dizziness, facial flushing, transient skin reactions, nausea, pain in the epigastric pain , paresthesia lower extremities. 


Hypersensitivity to the drug, acute porphyria , hemoblastosis in children.


No data.

Leave a Reply

Your email address will not be published. Required fields are marked *